Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,378,351
-$596,064 QoQ
Shares Held
140,297
-0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#763
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greenwich Wealth Management LLC holds $17,338,236 across 10 Drug Manufacturers - General names. PFE ranks #2 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,267 | $3,590,147 | |
| 2 | PFE |
Pfizer Inc
This page
|
140,297 | $3,378,351 | |
| 3 | LLY |
ELI LILLY & Co
|
2,759 | $3,309,227 | |
| 4 | NVS |
Novartis AG
|
11,294 | $1,769,995 | |
| 5 | GSK |
GSK plc
|
31,884 | $1,671,359 | |
| 6 | JNJ |
Johnson & Johnson
|
4,468 | $1,134,737 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,081 | $909,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,467 | $817,040 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,378,351 | 140,297 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,974,415 | 141,539 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,512,742 | 141,074 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,486,836 | 136,846 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,344,853 | 137,989 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,399,462 | 134,154 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,461,660 | 130,481 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,949,239 | 136,463 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $3,717,059 | 132,847 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,704,319 | 133,489 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,534,836 | 122,780 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,084,288 | 123,132 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $4,553,528 | 124,142 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $5,047,123 | 123,704 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,314,971 | 123,243 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $5,387,206 | 123,108 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,473,165 | 123,463 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $6,367,036 | 122,987 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $7,275,314 | 123,206 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $5,185,199 | 120,558 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $4,362,384 | 111,399 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $3,891,283 | 107,405 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,990,535 | 108,409 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,008,626 | 109,227 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $3,570,974 | 109,204 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,545,449 | 108,623 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||